Renaud Dehareng

Renaud Dehareng

Group Chief Executive Officer

Renaud became CEO in 2012, with a vision of increasing profitability and developing Curium into a global leader in nuclear medicine. He achieved this goal with great success, turning the organization into a larger, more vertically-integrated institution with a global reach

Renaud is now leveraging Curium’s unique global infrastructure and proven industry experience to serve its nuclear medicine clients with an emphasis on compliance, service reliability, operational excellence and new product development.

One of Renaud’s main achievements has been to pull together the best team of more than 2000 members worldwide to take Curium through its vision and strategy.

Renaud has been part of Curium and its predecessors’ companies since 2009. Prior to his current role, he was Group COO and CEO Europe. Previously, he served in Arthur Andersen’s strategic consulting division, which he joined after graduating from the UK’s Warwick Business School.

Renaud resides in Belgium with his wife and three children. In his spare time, he competes in triathlons and enjoys kite surfing.

Xavier Defourt

Xavier Defourt

Chief Legal Officer

As Chief Legal Officer, Xavier leads Curium’s legal team.

In this role, he and his team support Curium’s operations in their day-to day-legal questions and challenges, ensure corporate housekeeping of all entities, act as Secretary to the Board and Committees of the parent entities, supervise compliance with Group policies, ensure proper insurance coverage of all activities and entities, and assist members of the Group Leadership Team in the Group’s M&A, CMO and in-licensing projects.

Xavier holds more than ten years’ experience working as Attorney at the Brussels Bar, followed by 15 years’ experience as Chief Legal Officer at Ion Beam Applications S.A., the Belgian listed company active in cyclotron manufacturing, proton-therapy and dosimetry, which owned IBA Molecular until 2012.

Xavier holds a Master-in-Law from the University of Louvain-la-Neuve, Belgium, and a Post Master in Economic Law from the University of Gent, Belgium. Married with three children, Xavier is a keen ultra-trail runner and mountain lover.

Ciril Faia

Ciril Faia

Chief Strategy Officer

As Chief Strategy Officer, Ciril leads Curium’s strategy and corporate development.

In this role, he supports key growth initiatives at a group level, from ideation to scoping, business case modelling and implementation design – ensuring the Curium Group fulfils its mission, and is positioned on a sustainable, profitable growth track. This includes strategic planning, new product development, large-scale manufacturing and distribution partnerships, as well as supporting Curium’s inorganic initiatives.

Ciril has more than 16 years of experience in healthcare and strategy consulting, with a strong focus on growth strategy. Prior to his time at Curium, he served as Partner at one of the world’s leading management consultancies.

Ciril holds a master’s degree from ESSEC Business School (Paris), and is married with four children. He is a keen marathon runner and acts as an active Board Member of ‘Petits Princes’, a wish-granting charity for critically-/chronically-ill children.

Rudolf van Houten

Group Chief Financial Officer

Rudolf is the Group Chief Financial Officer with responsibility for Global Finance, Shared Services and IT.  He is a member of Curium’s Executive Committee.  Rudolf holds more than 25 years of finance experience gained working in the U.S., Europe and Asia.

Prior to joining Curium, Rudolf was Global Head of Group Finance for Takeda Pharmaceuticals based in Tokyo, Japan.  Before that, he spent 10 years as Group CFO for Aysta LifeScience, a private equity sponsored company in the crop protection industry.

Rudolf graduated from the College of William and Mary, in Virginia with a BBA in Finance and holds an MBA from IMD in Lausanne, Switzerland.

Grégoire Kantardjian

Chief People and Communications Officer

In his capacity as Chief People and Communications Officer, Gregoire leads all aspects of human resources – from the talent life cycle, managing internal recruitment teams, career development, and succession planning. Gregoire is also responsible for the development and delivery of Curium’s global communications, ensuring that external and internal communication programs align with Curium’s long-term corporate vision.

Prior to joining Curium, Grégoire was a Managing Director at leading executive search and leadership advisory firm Russell Reynolds Associates, where he served clients in the Healthcare sector globally for their C-level executive recruitment needs. As a member of the Leadership & Succession practice, he also conducted multiple executive assessments, team effectiveness, as well as CEO succession projects on a pan European basis.

Prior to his 15 years in executive search and talent advisory, Grégoire held various positions in strategy and management consulting, mainly on cross-border assignments dealing with pricing, purchasing and organization issues. Previously, he taught political science at the University of Aix-Marseille.

Born and raised in Switzerland, Grégoire graduated from the Ecole Normale Supérieure in Paris and holds a master’s degree in philosophy and law from the University of Paris II-Assas.

Sakir Mutevelic MD, MSc

Chief Medical Officer

As Chief Medical Officer, Sakir leads Curium’s global medical strategy and clinical development for diagnostic and therapeutic radiopharmaceuticals.

In this role, he develops and leads the key Curium`s product pipeline growth initiatives, to drive product evolution and portfolio expansion across radiopharmaceutical diagnostics, companion diagnostics and therapeutics ensuring the Curium Group fulfills its mission “Life Forward” to transform and improve the disease management and patient lives. This includes managing and coordinating strategic partnerships, strategic clinical development planning and operational execution, managing the clinical aspects of regulatory strategies and interactions with health authorities, as well as supporting Curium`s strategic initiatives from medical and clinical development perspective. Sakir is a member of Curium’s Global Leadership Team.

Sakir has more than 25 years of professional experience in the pharmaceutical industry, with profound clinical experience and successful clinical development track of both new chemical and biological entities in oncology and hematology from early to late stage clinical development as well as global regulatory submissions and approvals. Prior to his time at Curium, he served in different strategic and operational functions with increasing responsibility at country, regional and global level, at Boehringer Ingelheim, Baxter, Baxalta, Shire, Servier and AAA/Novartis

Sakir holds a medical doctor degree and master degree in pharmacology and is married with two children. He is a keen alpine skier and passionate about the mountains and the environment since a young age.

Michael Patterson

North America Chief Executive Officer

Mike is Curium’s North America Chief Executive Officer. He has executive responsibility for the organization’s business in the region, across areas including Operations, Finance and Commercial, and is a member of Curium’s Executive Committee.

Mike joined Curium in October 2017 as VP of Marketing for North America.  He has 25 years of professional experience in the pharmaceutical industry, most recently with Mallinckrodt in various roles including Marketing, Chief of Staff to the President of Commercial, and Managed Care.  He also worked at Sanofi in commercial roles including Sales, Sales Leadership and Marketing.

Mike holds an MBA from Washington University in St. Louis and a BS from the University of Illinois and resides in St. Louis with his wife and daughter. Mike enjoys running and playing golf.

John Sylvester

CEO SPECT International

John joined Curium in April 2020 and is responsible for the SPECT International business including the SPECT operations in Petten, Netherlands and Saclay, France and our International group.

Most recently John was the group Chief Commercial Officer for BTG, from 2011 until the successful 4.2 Bn USD sale of the company to Boston Scientific in August 2019. In this capacity, he played an instrumental role in growing BTG to a 900 M GBP business, including the acquisition of TheraSphere.

His career prior to BTG covers a series of commercial and general management roles for Rio Tinto Zinc plc, ICI plc, English China Clays where he was General Manager for their European and Asian Operations, as well as Baxter Healthcare where he was VP Marketing for their European Medication delivery business.

John has degrees in Biochemistry and Applied Molecular Biology from Manchester University in the UK. He lives in London with his partner and is a season ticket holder with Manchester United Football Club.

Chaitanya Tatineni

Chief Mergers and Acquisitions Officer

Chaitanya is the Chief Mergers and Acquisitions Officer at Curium and leads the Group’s M&A, integration and product in-licensing efforts across the globe. In this role, he is responsible for defining and executing the Group’s inorganic growth initiatives, in close collaboration with the Group’s Strategy, Commercial and Operations teams. Chaitanya is a member of Curium’s Executive Committee.

Prior to joining Curium, Chaitanya had more than 11 years of professional experience in investment banking, and had executed more than 20 transactions for pharmaceuticals, diagnostics and healthcare services clients across the US, Europe and Asia. He has previously worked for the healthcare investment banking teams at Jefferies, Bank of America Merrill Lynch and ABN AMRO banks in both London and Hong Kong.

Chaitanya holds an MBA from the Indian Institute of Management Ahmedabad and a bachelor’s degree in Electronics and Communication Engineering from the Indian Institute of Technology, Kharagpur.

Benoit Woessmer

Benoît Woessmer

PET Europe Chief Executive Officer

Benoît is PET Europe Chief Executive Officer and leads Curium’s operational activities across Europe. In this role, he supports all commercial activities, as well as managing the European PET facility network of Curium.

His focus is to develop the PET business across the region and to maintain a high-level of service quality to Curium’s customers.

Benoît has more than 20 years of experience in the medical imaging field, in both radiology and nuclear medicine. Prior to joining IBA Molecular (now Curium), Benoît served as Contrast Media Business Unit Director for Covidien Germany.

Benoît holds a Master’s Degree in Biology from UPMC (Paris), and a Master’s degree in Health Law from Descartes University (Paris). He is married with two children.